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Data accessDNAdigest's mission is to investigate and address the issues hindering efﬁcient and ethical genomic data sharing
in the human genomics research community. We conducted contextual interviews with human genomics re-
searchers in clinical, academic or industrial R&D settings about their experience with accessing and sharing
human genomic data. The qualitative interviews were followed by an online surveywhich provided quantitative
support for our ﬁndings. Here we present the generalised workﬂow for accessing human genomic data through
both public and restricted-access repositories and discuss reported points of frustration and their possible
improvements. We discuss how data discoverability and accessibility are lacking in current mechanisms
and how these are the prerequisites for adoption of best practices in the research community. We summarise
current initiatives related to genomic data discovery and present a new data discovery platform available at
http://nucleobase.co.uk.
© 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Consistent decreases in the cost of DNA sequencing due to the suc-
cess of next generation sequencing (NGS) technologies open up new
horizons in clinical research and practice. Personalised medicine is
expected to deliver faster diagnostics and provide more efﬁcient treat-
ments for a plethora of diseases (Karczewski, 2013). Despite the huge
success of the Human Genome Project (HGP; U.S. Department of
Energy Human Genome Project, 2014) there are multiple barriers that
separate society from the potential beneﬁts of the genetics clinic of
the future. Human genomics research relies on the availability of geno-
mic datasets that must be carefully selected, curated and analysed to
test a hypothesis. Unfortunately, although a large amount of genomic
data is generated around the world, individual researchers are still lack-
ing access to the necessary amounts of the speciﬁc data they need to
power their studies. Exemplary collaborative practices demonstrated
during the realisation of the HGP do not reﬂect the state of data sharing
in the community today: data sharing is not the default, but the excep-
tion. In general,many researchers and organisations have expressed sup-
port for increased data sharing but there are numerous well-known
hurdles including technical, cultural, and legal restrictions limiting the
extent to which data is shared (Hayden, 2013; Knoppers et al., 2014;
Lim, 2014; Pickard and Swan, 2014).
Data sharing has continually been recognised as important, not only
for the advancement of scientiﬁc knowledge, but also for the preserva-
tion of information: safeguarding against misconduct and veriﬁcation).
. This is an open access article underof conclusions (Maurer, 2006; Tenopir et al., 2011). The initiatives pro-
moting and facilitating data sharing throughout research communities
are continuously growing, slowly changing the existing paradigms
of scientiﬁc practices (Wellcome Trust, 2014a, 2014b). A number of sci-
entiﬁc journals already explicitly request raw data deposition to open
repositories prior to publication and the NIH has recently issued a new
data sharing policy that requires all publicly funded research output to
be shared as quickly as possible (National Institutes of Health (NIH),
2014).
Data sharing in human genomics is a multifaceted challenge
(Kosseim et al., 2014). Ethical considerations for use combined with
the uniqueness of the genome of an individual require special precau-
tions to enable sharingwhilst protecting data privacy. The genome itself
is personally identiﬁable information and standard anonymisation tech-
niques may be insufﬁcient, since even after anonymisation the remain-
ing informationmay still be subject to re-identiﬁcation of the individual
(Erlich and Narayanan, 2014). At the same time, in studies involving
human subjects, consent from data donors must be obtained to use
their data for research (Beauchamp, 2011). The consent forms are still
not widely standardised and may be either broad or narrow, which
may open or restrict the potential usage of the data, respectively. Nota-
bly, the process of obtaining consent for research use may generate an
implicit expectation that the collected data is widely shared and reused.
Here, we investigate the current extent of human genomic data
sharing by examining the data handling processes and needs of
human genomics researchers in different settings. We explore how re-
searchers are including data access and data sharing in their current
workﬂows andwhether any bottlenecks need to be addressed to enable
more efﬁcient data collaborations.the CC BY license (http://creativecommons.org/licenses/by/3.0/).
Fig. 1. The generalised workﬂow that researchers follow to access human genomic data based on qualitative interviews conducted with 20 researchers in academia, or a clinical or
industrial R&D setting. The main steps of the workﬂow are included and where possible, the duration of the steps according to the interview responses is indicated.
1 The survey was designed using the online survey tool Typeform (http://www.
typeform.com).
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Data on the current practices and experiences of accessing and shar-
ing data for human genomics research was collected using a combina-
tion of qualitative and quantitative methods. The qualitative research
was based on contextual inquiries in the form of guided interviews
(Whiteside et al., 1988). A follow-up survey was used to provide quan-
titative sizing information (vide infra). It was sent directly to ~200
knownhuman genetics researchers. Our contacts in this pool forwarded
the survey to the Sanger and EBI internal mailing lists. In addition, we
promoted the survey through our social media and sent it directly to
the communications/ofﬁce assistant of 158 research institutions and
clinics working with genomic data of which ~75 were in the UK and
the others from the rest of the world.
Participants for in-depth interviews were identiﬁed and contacted
from the genetic researcher community in the Cambridge and London
area within the UK, and in the Netherlands; where possible, the inter-
views were conducted in the researcher's own workspace. Interviews
were conducted one-to-one with a total of 20 researchers usinghuman genomic data either in a clinical, academic or industrial R&D set-
ting. In a guided discussion lasting approximately 30–60 min, the re-
searchers were questioned regarding their experience of i) ﬁnding and
gaining access to data, ii) managing and storing data, and iii) sharing
their own data. In addition, each interviewee was asked to draw a
workﬂow diagram, indicating the steps involved in accessing and shar-
ing data and the time required for each step. The interview responses
and workﬂows were documented per respondent. By comparison of
the workﬂow diagrams, common elements were identiﬁed and the
generalised workﬂow for data access was generated (Fig. 1).
A survey on the same topic as the in-depth interviews was designed
to collect quantitative information from a wider audience. The ques-
tions in the survey were designed as multiple-choice questions based
on the answers collected from the ﬁrst 10 interviews. We designed
the survey to be conducted online1 with 17 mandatory questions relat-
ed to researcher practices and experiences with data access and data
Fig. 2. Survey responses to the question: “How often do you access datasets from public/
restricted repositories?”. A total of 65 respondents completed the survey. The distribution
of frequency of access was similar for all respondent groups independent of the afﬁliation
(comparison between groups not shown).
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three optional questions regarding opt-in for re-contact regarding the
outcome of the research. To increase the survey reach, we emailed the
survey link to mailing lists in the genomics research community. By
the timeof submission of this paper a total of 652 individuals had visited
the survey page and a total of 65 had completed the survey. Approxi-
mately half of the respondents were from the UK.2
The survey results were summarised per question into percentages,
and for the questions related to frequency of data access we compared
the frequency of public versus restricted-access data sets for industry
versus academic researchers (Fig. 2). In the following sections, all per-
centages quoted are from the survey results. The results were plotted
as bar charts using Microsoft Excel. The ﬁnal results of the survey are
available at: http://dnadigest.org/surveys/.
3. Results
3.1. Data access and data management
The interview results revealed many commonalities in the way ge-
nomic data is accessed andmanaged. These patterns point to a general-
isedworkﬂow that researchers followwhen searching for and accessing
human genomic data. Institutions differ in which databases they access
and how efﬁcient their data access process is, but the common steps
that all the interviewees follow in their practice are represented in
Fig. 1. In most cases, there is a substantial lead time for accessing geno-
mic data and the only two routes to fast data access involve using i) in-
house databases or those of collaborators and ii) open/public access da-
tabases where no additional institutional approval is necessary. In the
cases when a relevant dataset is neither present in an open database
nor provided by collaborators, researchers will try to access data from
a restricted-access database, such as EGA or dbGaP. This process of
accessing data from a restricted-access repository was reported as a
time-consuming and frustrating experience.
The following four bottlenecks were identiﬁed from the interview
responses:
i) Finding relevant and usable data (data discovery). Searching for
relevant data is haphazard for most interviewees and usually
involves a general web keyword search, visiting one or more of
their favourite databases, searching through a journal database
and/or tracing the data referenced in a published article, or a
word-of-mouth search which involves enquiring about data
from colleagues and collaborators. One researcher said: “About
half my time is spent assessing data and talking to collaborators to
see if it is relevant.”
ii) Getting authorisation to access data. Once a dataset has been iden-
tiﬁed, some researchers need to make a case to their supervisor
and/or IT department for the importance of the dataset and this
request is usually escalated through the organisation. In some
cases, even if approval is granted it may be for very limited use
of the data under strict conditions. Additionally, if the data is
being shared between institutions (e.g. academia and industry)
it may take signiﬁcant time to draw up a legal contract about in-
tellectual property, ownership of results, publication authorship,
responsibility for data, etc. As a result, a legal contract between
collaborators and ethical approval can take up to six months:
“Inter-institutional collaboration can take many months because of
the legal requirements of sharing data, in which time the research
can change direction or the collaboration may be cancelled entirely.”
iii) Formatting data. This step includes converting ﬁle types,
standardising, performing quality control for reliability and
relevance and customising data for speciﬁc applications. This is2 The ﬁnal results from the surveywith complete demographics are available at: http://
dnadigest.org/surveys.another time consuming process that can take up to one month:
“When I start a new research project, one of the biggest bottlenecks
is searching for and formatting large amounts of data from multiple
websites into a usable form because it is not standardised.”
iv) Storing andmoving data. Storing andmoving data are often a prob-
lem because of the large size of genomic data sets and therefore
require special arrangements, for example, transportation on a
hard-drive: “The size of genetic data (terabytes-petabytes) that
needs to be downloaded, processed and moved is a burden.”
In smaller organisations, genomics researchers are responsible for
handling data themselves and therefore need to spend a signiﬁcant
amount of their time completing steps i)–iv) for data access,whilst larg-
er organisations usually have a supporting team of bioinformaticians or
technicians that may assist steps ii)–iv). All interviewees reported that
the resources and time required to access data are a hurdle. In some
cases, delays in accessing data may be so long and/or the process so
complicated that the research question can become outdated before
the data is actually retrieved or used. In academic research, data sharing
may happenwith collaborating groups, either with formal guidelines as
a part of research consortia or informally between researchers working
on a project together. Researchers in industry mentioned that any col-
laboration that includes sharing of results or data with external groups
requires legal agreements to determine the rights to any intellectual
property resulting from the collaboration. This requirement was indi-
cated as a barrier for sharing due to the resources and time involved
to put a legal agreement in place.
Several researchers expressed that the time and effort involved in
accessing certain types of data have been built into their workﬂow:
they know that projects involving certain kinds of data cannot be time
critical, they always work in parallel, jobs have been created speciﬁcally
to handle data, and long periods of waiting are part of the status quo. In
some cases, instead of initiating the lengthy process of ﬁnding and
accessing data, the problems and delays are avoided by simply limiting
research questions to those that can be answeredwith existing datasets.
All intervieweesmentioned that usefulness of genomic data for their
project is determined by quality of both data and metadata and how
well this metadata is curated and organised. The metadata may include
information about the research subject (a healthy individual or a
patient), type of disease and ethnic group, and technical information
on the way the sample was obtained and handled to generate the data.
The majority of the interviewees communicated that having access
tomore data (possibly even from repositories beyond their knowledge)
would stimulate their research. Some clinical researchers reported frus-
tration at having to search for clinical data that they felt had probably
been found and accessed by colleagues in their institution before, but
not made available for sharing within the institution. Almost all inter-
viewees stated that tools that would allow discovery of new datasets
and facilitate access to such datasets would open up more research
103T.A. van Schaik et al. / Applied & Translational Genomics 3 (2014) 100–104possibilities and also, importantly, improve the statistical power and
signiﬁcance of their results.
3.2. Data sharing
Interviewees generally had limited experience of making their own
data available. The process of sharing data through deposition in
restricted-access repositories was reported to be difﬁcult and time-
consuming mainly because data has to be formatted to meet strict and
sometimes inﬂexible requirements. In addition, completing the forms
describing the scope of the consent for data usage and obtaining the re-
quired institutional approvals may be a complicated and resource-
intensive process. Regardless of existing data sharing policies which
vary across institutions, even when researchers are authorised to
share data they report reluctance to do so because of the amount of ef-
fort required. They did unanimously agree that the research community
would beneﬁt from more data sharing. In general, they only share data
when forced to through publication, when speciﬁcally requested to do
so by another researcher, or when ofﬁcially collaborating in order to
share data. One interviewee responded: “My perception is that sharing
human genomic data would be difﬁcult but I would be willing to go
to greater lengths to share data because I believe it is important; more
data sharing would open up new research opportunities and promote
transparency and reproducibility in results”.
There was a clear difference between the three categories of re-
searchers regarding their reasons for not making more of their own
data available to others evenwhen they have the authority and consent
to do so. Clinical geneticists cited a lack of time because their main pri-
ority is diagnosing patients. Industrial researchers cited a lack of time
because of the pressure to meet the deadlines in their job. Researchers
in academia cited both a concern about the potential loss of future pub-
lications once unpublished data is shared, and the lack of time and in-
centive to share data as this does not contribute to their publication
record. Researchers from all categories felt that they lacked sufﬁcient
resources to make their data available.
3.3. Survey responses
The results of the online survey, containing questions addressing the
issues we identiﬁed through the interviews, showed very good agree-
ment with the ﬁndings described above.
3.3.1. The value of data sharing
The majority of the survey respondents indicated that they perceive
a lot of value from sharing data andmaking their data available: “Access
to more data means more statistical power for validation” (89% agree),
“Access to more data means better representation of genetic variation”
(83% agree) and “Sharing data reduces duplication of effort” (83%
agree).
3.3.2. Making data available
Although the respondents demonstrated broad agreement with the
advantages of data sharing, 40% indicated that they share their data only
internally or with collaborators on the same project and 31% indicated
that they share their data only after a manuscript has been submitted
for publication.
3.3.3. Accessing existing datasets
The frequency of accessing different data repositories varied greatly
between publicly available and restricted-access databases. 49% of the
respondents indicated that they access publicly available datasets at
least once per week, in stark contrast to restricted-access data sets
which only 8% of respondents would access at least once per week,
46% would access twice per year or less, and 26% said they would
never access restricted-access data sets (Fig. 2). The top-ﬁve most
accessed resources for human genomic data are 1000 Genomes(indicated by 63% of survey respondents), UCSC (61%), ClinVar (33%),
GEO (30%), and COSMIC (26%). Notably, all these resources are
free and open access databases. Themost-accessed restricted-access re-
pository was dbGaP (24%). Information about other databases is avail-
able at the survey results page (http://dnadigest.org/surveys).
3.3.4. Data access bottlenecks
When asked about the bottlenecks in accessing data, 57%mentioned
compatibility issues, 52% mentioned the approval process from the
repository holding the data, and another 52% mentioned the size and
the time required to download data. Nearly half of the survey respon-
dents indicated that data discovery on its own consumed at least 20%
of their time in relation to a research project.
3.3.5. Respondent demographics
46% of the survey respondents were from the UK, 20% from the
USA and 34% from the rest of the world. Approximately 57% of them in-
dicated an academic afﬁliation. The research areas of the respondents
were mainly complex diseases (34%), rare diseases (29%), cancer
(26%) and diagnostics (25%); several respondents indicated multiple
areas of research.
4. Discussion
The results of our interviews and survey demonstrate that there is a
strong desire amongst researchers to access genomic data beyondwhat
is available at their institution. In addition, our respondents expressed a
willingness to make data available for sharing, provided that they have
consent and permission to do so. However, they mentioned a number
of difﬁculties regarding ﬁnding, accessing and using available data
resources. The respondents reported that the effort and resources re-
quired for both accessing data and for making data available through
current mechanisms are limiting their adoption of data sharing prac-
tices. From our survey results we noted a stark contrast between the
usage of public versus restricted-access datasets which we suggest is a
direct result of the effort required to access these datasets. The voiced
concerns regarding the accessibility and general usability of restricted-
access repositories echo recent ﬁndings in a survey of the dbGaP user
base (Simpson et al., 2014). We see the difﬁculty of both data access
and data sharing as an indicator of a general problem with current data
sharing mechanisms: we believe that the ease of use, discoverability,
availability and accessibility of data resources are crucial for promoting
and facilitating data sharing for the genomics research community.
The challenges of data sharing have been discussed extensively in
the human genomics research community, since sharing of samples,
data and results is an essential building block for progressing the body
of knowledge in the ﬁeld (Callier et al., 2014). Several organisations in-
cluding the Research Data Alliance (RDA; https://rd-alliance.org) and
the Human Variome Project (HVP; http://www.humanvariomeproject.
org) have made great efforts to promote capturing and sharing of
research data, but hurdles in sharing genomic data still remain.
In 2013, the Global Alliance for Genomics and Health (GA4GH; http://
genomicsandhealth.org) was established and has since engaged more
than 180 institutions and organisations in working groups to address
the challenges of regulatory restrictions, ethics, clinical demands, data
representation, storage, analysis, and security related to genomic data
sharing.
DNAdigest (http://dnadigest.org) is a charity that takes part in this
effort by organising collaborativeworkshopswith the research commu-
nity to develop new open source tools and prototype solutions. The ﬁrst
output of these efforts is a data discovery platform which is now under
development by the social enterprise Nucleobase. The objective of this
platform is to facilitate the data discovery process by making it a social
and collaborative effort, which beneﬁts not only an individual researcher
but also their peers and collaborators. The ﬁrst beta-version of this
platform is available at http://nucleobase.co.uk.
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prove the discoverability of genomic data across locations include: the
Beacon project and theMatchmaker exchange (from theGlobal Alliance
for Genomics and Health working groups), the Leiden Open Variation
Database (LOVD) (Fokkema et al., 2011), ClinVar (Landrum et al.,
2014), Cafe Variome (http://cafevariome.org) and PhenomeCentral
(https://phenomecentral.org). Some of these initiatives focus on identi-
ﬁcation of speciﬁc genetic variants within public or restricted-access
datasets (the Beacon project and Cafe Variome), others focus on report-
ed correlations between variants and disease (LOVD and ClinVar), and
others focus primarily on matching of phenotype information for
individual samples to initiate contact between clinicians (Matchmaker
exchange and PhenomeCentral). The DNAdigest data discovery plat-
form is a portal to discover the existence of datasets across public and
restricted-access repositories based on their metadata, descriptions
and annotations contributed by the community. This approach offers
complementary functionality to the aforementioned initiatives.
5. Conclusion
We identiﬁed the current challenges and bottlenecks in genomic
data sharing and data access through in-depth qualitative interviews
combined with an online survey designed to quantify the extent of
genomic researchers' experience with data access and data sharing.
We found that the steps involved in both data access and data
sharing through restricted-access repositories are perceived as time-
consuming and difﬁcult. We conclude that availability, discoverability
and accessibility of data resources are a critical ﬁrst step to improve
data sharing in genomics.
We think that it is important to continuously assess available solu-
tions which facilitate data sharing/access and promote themechanisms
and practices that make the greatest impact. We believe that there is a
need for more activities to develop and promote best practices before
genomic data sharingwill become the default rather than the exception.
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